Skip to main content
GALECTIN THERAPEUTICS INC logo

GALECTIN THERAPEUTICS INC — Investor Relations & Filings

Ticker · GALT ISIN · US3632252025 LEI · 5299004HFYSAZM2ALW85 US Manufacturing
Open in API
Filings indexed 1,091 across all filing types
Latest filing 2013-05-30 Director's Dealing
Country US United States of America
Listing US GALT

About GALECTIN THERAPEUTICS INC

https://galectintherapeutics.com/

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for fibrotic diseases, chronic liver disease, and cancer. The company's therapeutic approach centers on inhibiting the galectin-3 protein, which is implicated in various inflammatory, fibrotic, and malignant conditions. Its lead drug candidate, belapectin (GR-MD-02), is a proprietary carbohydrate-based drug designed to bind to and inhibit galectin-3. The primary development program for belapectin is focused on treating non-alcoholic steatohepatitis (MASH) with cirrhosis, a serious liver disease with no currently approved therapies.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2013-05-30 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text indicates it is furnishing a press release related to an updated phone number for accessing the audio portion of a presentation following the company's 2013 Annual Meeting of Shareholders. The document explicitly states that the information is being furnished and not filed, and it does not contain any financial statements or detailed report content. The length is 3366 characters, which is relatively short and consistent with an announcement rather than a full report. There is no substantive financial data or detailed report content present. Therefore, this document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes current reports like Form 8-K that do not contain detailed financial data or report content.
2013-05-23 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text indicates it is a Regulation FD Disclosure with an attached press release dated May 15, 2013. The document explicitly states that the press release is being furnished and not filed, and no financial statements or substantive financial data are included. The document length is 2932 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication of quarterly or annual financial results, management discussion, or other detailed financial data. Therefore, this document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2013-05-15 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02, which is "Results of Operations and Financial Condition," and states that a press release containing financial information for the quarter ended March 31, 2013, is being furnished. The document itself does not contain detailed financial statements or substantive financial data but rather references a press release (Exhibit 99.1) that contains the financial results. The document length is only 2234 characters, which is quite short and consistent with an announcement rather than a full report. According to the rules, if a document is short and states that a report or release is furnished or attached, it should be classified as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Earnings Release (ER). Although the content relates to quarterly financial results, the document is a Form 8-K current report announcing the release of financial results, not the full report itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2013-05-10 English
FORM 10-Q
Interim / Quarterly Report Q1 2013
2013-05-10 English
PRIMARY DOCUMENT
Director's Dealing
2013-05-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.